MLAB vs TRMB
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
MLAB · Mesa Laboratories$128.25 ▲ 7.50%
TRMB · Trimble$54.11 ▲ 0.88%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- MLAB +57.7%
- TRMB -32.1%
Head to head
| Metric | MLAB | TRMB |
|---|---|---|
| Price | $128.25 | $54.11 |
| Change today | ▲ 7.50% | ▲ 0.88% |
| Market cap | $717.67M | $12.40B |
| Return, 3 months | +26.4% | -7.4% |
| Return, year to date | +64.1% | -30.9% |
| Return, 1 year | +69.8% | -31.4% |
| P/E (TTM) | 150.9 | – |
| P/B | 3.8 | 2.5 |
| P/E percentile vs own 5y | 66th | 5th |
| Dividend yield | 0.50% | – |
| Revenue growth (YoY, latest qtr) | +1.0% | +11.0% |
| Net profit growth (YoY) | -40.3% | -628.8% |
| Gross margin | 64.2% | 69.8% |
| Operating margin | 9.0% | 17.7% |
| Net margin | 1.9% | -2.8% |
| Return on equity | 2.7% | -1.9% |
| Analyst target vs. price | – | +36.6% |
| Analyst buy share | – | 91% |
| RSI (14) | 51 | 33 |
| 30-day volatility | 49.3% | 61.2% |
| Max drawdown, 1 year | -24.2% | -41.5% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- TRMB is the largest of the group by market value.
- MLAB has returned the most over the past year.
- TRMB is growing revenue fastest.
- MLAB keeps the most profit per dollar of sales.
- MLAB has been the calmest stock over the last 30 days.